- Home
- CRSR vs KROS Comparison
CRSR vs KROS Comparison
Compare CRSR & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRSR | KROS |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 723.6M | 584.9M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CRSR | KROS |
|---|---|---|
| Price | $5.46 | $14.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $8.50 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 3.5M | 263.3K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.37 | 3.85 |
| EPS | N/A | ★ 2.68 |
| Revenue | ★ $1,472,480,000.00 | N/A |
| Revenue This Year | $0.51 | $6,898.87 |
| Revenue Next Year | $5.61 | N/A |
| P/E Ratio | ★ N/A | $5.62 |
| Revenue Growth | ★ 11.86 | N/A |
| 52 Week Low | $4.48 | $9.12 |
| 52 Week High | $12.00 | $22.55 |
Technical Indicators
Market Signals| Indicator | CRSR | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 49.17 | 20.59 |
| Support Level | $5.44 | $13.42 |
| Resistance Level | $6.08 | $15.02 |
| Average True Range (ATR) | 0.47 | 0.59 |
| MACD | 0.05 | -0.20 |
| Stochastic Oscillator | 30.78 | 0.69 |
Price Performance
Historical ComparisonAbout CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.